-
Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trialSaad M, Fuernau G, Thiele H et al. -
Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial InfarctionPöss J, Köster J, Fuernau G et al.
-
Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK TrialP Guedeney, O Barthélémy, M Zeitouni et al. cardiogenic shockpercutaneous coronary interventionSYNTAX score
-
Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR)Dasari TW, Hamilton S, Chen AY et al.
-
The Wait for High-Sensitivity Troponin Is Over—Proceed CautiouslyKorley FK
-
Impact of the US Food and Drug Administration–Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial InfarctionMR Gimenez, P Badertscher, R Twerenbold et al.
-
Wearable Cardioverter-Defibrillator after Myocardial InfarctionOlgin JE, Pletcher MJ, VEST Investigators et al.
-
Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trialAbdin A, Pöss J, Thiele H et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
